These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8329831

  • 21. Insulin and growth factors adaptation to normal puberty.
    Savage MO, Smith CP, Dunger DB, Gale EA, Holly JM, Preece MA.
    Horm Res; 1992; 37 Suppl 3():70-3. PubMed ID: 1427646
    [Abstract] [Full Text] [Related]

  • 22. Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion.
    Beaufrère B, Beylot M, Metz C, Ruitton A, François R, Riou JP, Mornex R.
    Diabetologia; 1988 Aug; 31(8):607-11. PubMed ID: 3065115
    [Abstract] [Full Text] [Related]

  • 23. Insulin and insulin-like growth factors in diabetes mellitus.
    Dunger DB.
    Arch Dis Child; 1995 Jun; 72(6):469-71. PubMed ID: 7618926
    [No Abstract] [Full Text] [Related]

  • 24. Diurnal serum growth hormone levels in poorly and well-controlled juvenile diabetics.
    Johansen K, Hansen AP.
    Diabetes; 1971 Apr; 20(4):239-45. PubMed ID: 5551345
    [No Abstract] [Full Text] [Related]

  • 25. Immunoreactive growth hormone in plasma and urine in juvenile diabetics before and during initial insulin treatment.
    Hanssen KF.
    Acta Endocrinol (Copenh); 1974 Jan; 75(1):50-63. PubMed ID: 4406481
    [No Abstract] [Full Text] [Related]

  • 26. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.
    Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV.
    N Engl J Med; 1986 Jul 24; 315(4):215-9. PubMed ID: 3523245
    [Abstract] [Full Text] [Related]

  • 27. Circadian rhythm of growth hormone, free and total insulin during the treatment with artificial B-cell (Biostator GCIIS).
    Sieradzki J, Szybiński Z, Izworski A, Gołda W.
    Endokrynol Pol; 1983 Jul 24; 34(2):73-80. PubMed ID: 6354700
    [No Abstract] [Full Text] [Related]

  • 28. [The role of growth hormone in the development of complications in insulin-dependent diabetes].
    Krawczuk-Rybak M, Urban M.
    Padiatr Grenzgeb; 1991 Jul 24; 30(3):237-43. PubMed ID: 2067873
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM, Yuen K, White D, Mallard B, Dalton RN, Acerini CL, Dunger DB.
    Clin Endocrinol (Oxf); 2006 Oct 24; 65(4):439-45. PubMed ID: 16984235
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
    Cotterill AM, Daly F, Holly JM, Hughes SC, Camacho-Hübner C, Abdulla AF, Gale EA, Savage MO.
    Clin Endocrinol (Oxf); 1995 Nov 24; 43(5):567-74. PubMed ID: 8548941
    [Abstract] [Full Text] [Related]

  • 33. [Sensitivity to insulin in patients with diabetes mellitus].
    Levchenko TP.
    Probl Endokrinol (Mosk); 1984 Nov 24; 30(5):13-6. PubMed ID: 6095255
    [Abstract] [Full Text] [Related]

  • 34. Brief report: treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes.
    Usala AL, Madigan T, Burguera B, Sinha MK, Caro JF, Cunningham P, Powell JG, Butler PC.
    N Engl J Med; 1992 Sep 17; 327(12):853-7. PubMed ID: 1508245
    [No Abstract] [Full Text] [Related]

  • 35. Nocturnal blood glucose and IGFBP-1 changes in type 1 diabetes: Differences in the dawn phenomenon between insulin regimens.
    Yagasaki H, Kobayashi K, Saitou T, Nagamine K, Mitsui Y, Mochizuki M, Kobayashi K, Cho H, Ohyama K, Amemiya S, Nakazawa S.
    Exp Clin Endocrinol Diabetes; 2010 Mar 17; 118(3):195-9. PubMed ID: 19834874
    [Abstract] [Full Text] [Related]

  • 36. Clinical uses of insulin-like growth factor I.
    Bondy CA, Underwood LE, Clemmons DR, Guler HP, Bach MA, Skarulis M.
    Ann Intern Med; 1994 Apr 01; 120(7):593-601. PubMed ID: 8116999
    [Abstract] [Full Text] [Related]

  • 37. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
    Bach MA, Chin E, Bondy CA.
    J Clin Endocrinol Metab; 1994 Oct 01; 79(4):1040-5. PubMed ID: 7525624
    [Abstract] [Full Text] [Related]

  • 38. Clinical uses of insulin-like growth factor I.
    Hussain MA, Froesch ER.
    Adv Endocrinol Metab; 1995 Oct 01; 6():143-65. PubMed ID: 7671094
    [No Abstract] [Full Text] [Related]

  • 39. A role of free insulin-like growth factor-I in dawn phenomenon in children and adolescents with type 1 diabetes mellitus.
    Kobayashi K, Kobayashi K, Mochizuki M, Matsushita K, Sawanobori E, Ishihara T, Higashida K, Amemiya S.
    Endocr J; 2000 Mar 01; 47 Suppl():S91-3. PubMed ID: 10890193
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.